Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus , Coagulase-Negative Staphylococci, Enterococcus faecalis , and Enterococcus faecium
- 1 March 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (3) , 721-724
- https://doi.org/10.1128/aac.42.3.721
Abstract
The activities of the oxazolidinone antibacterial agents eperezolid (PNU-100592) and linezolid (PNU-100766) were compared with that of vancomycin against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus ( n = 200), coagulase-negative staphylococci ( n = 100), and vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium ( n = 50). Eperezolid and linezolid demonstrated good in vitro inhibitory activity, regardless of methicillin susceptibility for staphylococci (MIC at which 90% of the isolates are inhibited [MIC 90 ] range, 1 to 4 μg/ml) or vancomycin susceptibility for enterococci (MIC 90 range, 1 to 4 μg/ml). In time-kill studies, eperezolid and linezolid were bacteriostatic in action. A postantibiotic effect of 0.8 ± 0.5 h was demonstrated for both eperezolid and linezolid against S. aureus , S. epidermidis , E. faecalis , and E. faecium.Keywords
This publication has 10 references indexed in Scilit:
- In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsAntimicrobial Agents and Chemotherapy, 1996
- Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditisAntimicrobial Agents and Chemotherapy, 1994
- Antibacterial oxazolidinones: In vitro activity of a new analogue, E3709Diagnostic Microbiology and Infectious Disease, 1992
- In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococciJournal of Antimicrobial Chemotherapy, 1992
- Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compoundAntimicrobial Agents and Chemotherapy, 1988
- Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesisAntimicrobial Agents and Chemotherapy, 1988
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988
- In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105Antimicrobial Agents and Chemotherapy, 1988
- In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1988
- Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721Antimicrobial Agents and Chemotherapy, 1987